P492: SAFETY AND EFFICACY OF LP-108 AS MONOTHERAPY AND COMBINED WITH AZACITIDINE IN PATIENTS WITH RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROMES, CHRONIC MYELOMONOCYTIC LEUKEMIA, OR ACUTE MYELOID LEUKEMIA
Kristin Koenig,
Juan Miguel Bergua Burgues,
Pau Montesinos,
Alison Walker,
Dale Bixby,
Patrick Burke,
Naval Daver,
Marina Konopleva,
Stephen Anthony,
Fenlai Tan,
Yi Chen,
Yu Chen,
Yue Shen,
Emily Curran
Affiliations
Kristin Koenig
1 The Ohio State University College of Medicine, Division of Hematology
Juan Miguel Bergua Burgues
2 Hospital San Pedro de Alcantara, Hematology Department
Pau Montesinos
3 University Hospital La Fe, Department of Hematology
Alison Walker
4 H. Lee Moffitt Cancer Center and Research Institute, Division of Malignant Hematology
Dale Bixby
5 Hematology (Internal Medicine), University of Michigan
Patrick Burke
5 Hematology (Internal Medicine), University of Michigan
Naval Daver
6 Department of Leukemia, The University of Texas MD Anderson Cancer Center
Marina Konopleva
6 Department of Leukemia, The University of Texas MD Anderson Cancer Center
Stephen Anthony
7 Newave Pharmaceutical Inc.
Fenlai Tan
7 Newave Pharmaceutical Inc.
Yi Chen
7 Newave Pharmaceutical Inc.
Yu Chen
7 Newave Pharmaceutical Inc.
Yue Shen
8 Guangzhou Lupeng Pharmaceutical Co., Ltd.
Emily Curran
9 University of Cincinnati, Division of Hematology & Oncology
